Boston Biopharmaceutical Company Licenses Technology from Case Western Reserve University

Vision Medicines, a clinical-stage biopharmaceutical company in Boston that is developing therapies for patients suffering from retinal degeneration diseases, announced a licensing agreement with Case Western Reserve University for a drug candidate for the treatment of Stargardt disease.

Read More  >